SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
810That's nice information but what do they now with that information ? Will thMadharry-5/19/2003
809Is it utterly fanciful to think that if they had paid GNSC (for example) to 'nigel bates-5/19/2003
808Bingo, riding the coattails of Genentech news this morning. Congrats on all lonSpartex-5/19/2003
807"Take this drug, there's a one in three chance that it will do you someA.J. Mullen-5/19/2003
806Regeneron's Chief Scientific Officer Updates AXOKINE Obesity Data and Plans nigel bates-5/19/2003
805Nat Biotechnol 2003 May 5; High-throughput engineering of the mouse genome coMiljenko Zuanic-5/8/2003
804No problems! They can always say, "we have more potent candidate". &lMiljenko Zuanic-5/8/2003
803PDLI pulls plug on its anti-IL-4 Mab for asthma. Message 18925764keokalani'nui-5/8/2003
802Schleifer today mentioned (If correct and true) that over eleven hundreds subjecMiljenko Zuanic-5/8/2003
801Among several VEGF-Trap abstract at AVOR, one work is with Noivartis collaboratiMiljenko Zuanic-5/4/2003
800It started! Press Release Source: Milberg Weiss Bershad Hynes & Lerach LLP Miljenko Zuanic-5/2/2003
799<<Normaly, REGN will wait until they complete PIII trial(s), and IF positiMiljenko Zuanic-5/2/2003
798That Mr. Yankopoulos- he sure picked a good time to buy that new house! I guess Madharry-5/2/2003
797From VRTX 1Q PR: "As part of a broad strategy to develop pralnacasan for tMiljenko Zuanic-4/24/2003
796WE, REGN made many mistakes and CV is one of them. But, not the biggest one. ThMiljenko Zuanic-4/23/2003
795<<I am sorry for your loss.>> Thanks. <<I know very little abMiljenko Zuanic-4/23/2003
794Well I spent a few minutes reviewing some of the filings- that convertible offerMadharry-4/23/2003
793This board could probably use a little more recovery time before talking about rkeokalani'nui-4/23/2003
792I am sorry for your loss. I know very little about this company other than its oMadharry-4/23/2003
791It is possibility. Mild immunosuppressive agent may help reduce antigenic responMiljenko Zuanic-4/15/2003
790Is there analogy to mtx and remicade?keokalani'nui-4/15/2003
789Appears that weight loss slope is similar to data from PIII for first three montMiljenko Zuanic-4/14/2003
788Press Release Source: Regeneron Pharmaceuticals, Inc. Regeneron's AXOKINE Biotech Jim-4/14/2003
787Strange, May 9, is far away. Bottom price that Novartis will pay was 20/share. Miljenko Zuanic-4/10/2003
786A Disappointing Obesity Drug Trial By ANDREW POLLACK [NYT] April 1, 2003 Sharsim1-4/1/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News